Arno Therapeutics, Inc 4

4 · Arno Therapeutics, Inc · Filed Apr 11, 2016

Form 4

Period: 2016-04-07

Director

Transactions

Award
Stock Option (right to buy)
2016-04-07+88,628→ 88,628 total
Exercise: $0.37Exp: 2026-04-07→ Common Stock (88,628 underlying)

Holdings

Stock Option (right to buy)
Exercise: $8.00Exp: 2020-11-05→ Common Stock (3,750 underlying)
3,750
Stock Option (right to buy)
Exercise: $0.85Exp: 2024-11-04→ Common Stock (136,784 underlying)
136,784
2013 Series D Warrants (right to buy)
(indirect: By LLC)
Exercise: $2.14From: 2013-10-29Exp: 2018-10-29→ Common Stock (1,285,046 underlying)
1,285,046
Common Stock
(indirect: By LLC)
4,472,905
Stock Option (right to buy)
Exercise: $2.40Exp: 2023-11-04→ Common Stock (205,344 underlying)
205,344
Stock Option (right to buy)
Exercise: $2.90Exp: 2024-01-24→ Common Stock (34,224 underlying)
34,224
2012 Series A Warrants (right to buy)
(indirect: By LLC)
Exercise: $1.36From: 2013-10-29Exp: 2017-11-26→ Common Stock (1,531,861 underlying)
1,531,861
Stock Option (right to buy)
Exercise: $0.36Exp: 2025-11-04→ Common Stock (48,399 underlying)
48,399

Footnotes (6)

[F1]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
[F2]Currently exerciseable.
[F3]Vests in equal 36-monthly installments commencing 12/4/13.
[F4]Vests in equal 36-monthly installments commencing 12/4/14.
[F5]Vests in equal 36-monthly installments commencing 12/4/15.
[F6]Vests in equal 12-monthly installments commencing 5/7/16.

Documents

1 file